Skip to main content

Another Milestone in COVID-19 Vaccine Research

Posted on by

researchers vaccine
Glad to join Anthony Fauci (left), head of NIH’s National Institute of Allergy and Infectious Diseases, and Matt Hepburn (center), Department of Defense, at NIH on July 27, 2020, to launch the first efficacy trial of an investigational vaccine for COVID-19 under Operation Warp Speed. Credit: NIH


  • Grace (De Nicola, Nicoll, Householder) Linn says:

    Thank You so much for all that you folks have done. I will be 98 in October, will people in our age group be able to get the vaccine when it is ready? I am in fairly good health and still sound of mind.

    • Moderator says:

      Thank you, Grace. We appreciate your kind words. Scientists and public health experts are currently discussing how a safe, effective COVID-19 vaccine will be rolled out in the United States, once it becomes available. Certainly, older adults are a critical patient population to reach, regardless of age. That will be a key consideration in our planning discussions. Thanks again for your kind note. Stay well!

  • Gaynelle Green says:

    I was interested in being a part of the trials as a minority in my late 50s with hypertension, Cholesterol, and thyroid. Otherwise, I’m in good health.

Leave a Comment